August 14th 2024
Jason A. Mouabbi, MD, discusses challenges associated with diagnosing and managing invasive lobular carcinoma
July 23rd 2024
Jason A. Mouabbi, MD, discusses clinical trials aimed at expanding the treatment paradigm for invasive lobular breast cancer.
June 28th 2024
Jason Abdou Mouabbi, MD, discusses considerations for the use of ribociclib vs abemaciclib in patients with HR-positive, HER2-negative breast cancer.